Showing results (51-60 of 63) with videos related to
Sort By:
Pageof 7
The Journal of Infectious Diseases|March 3, 2007
High rates of forward transmission events after acute/early HIV-1 infectionBluma G Brenner, Michel Roger, Jean-Pierre Routy, et al.AIDS (London, England)|February 26, 2021
Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIVAmanda K Jan, Julia V Moore, Richard J Wang, et al.AIDS (London, England)|February 27, 2024
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm deliveryRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.Plos One|May 16, 2019
HIV infection is associated with elevated biomarkers of immune activation in Ugandan adults with pneumoniaRichard J Wang, Julia Moore, Daniela Moisi, et al.Frontiers in Immunology|August 15, 2022
Methotrexate Inhibits T Cell Proliferation but Not Inflammatory Cytokine Expression to Modulate Immunity in People Living With HIVMichael L Freeman, Brian M Clagett, Daniela Moisi, et al.Open Forum Infectious Diseases|June 23, 2021
Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV InfectionSamuel R Schnittman, Helen Byakwaga, Yap Boum, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|June 6, 2025
Inflammation, antiretroviral therapy continuation, and HIV disease progression in postpartum women with HIVRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.Cell Reports. Medicine|September 25, 2024
Sirolimus reduces T cell cycling, immune checkpoint marker expression, and HIV-1 DNA in people with HIVTimothy J Henrich, Ronald J Bosch, Catherine Godfrey, et al.Pathogens & Immunity|August 21, 2024
Comparison Study of the Bio-Plex and Meso Scale Multiplexed SARS-CoV-2 Serology Assays Reveals Evidence of Diminished Host Antibody Responses to SARS-CoV-2 after Monoclonal Antibody TreatmentUrvi M Parikh, Amy L Heaps, Daniela Moisi, et al.Pathogens & Immunity|September 9, 2024
Impact of SARS-CoV-2 Resistance to Antiviral Monoclonal Antibody Therapy on Neutralizing Antibody ResponseMarc-Kendy Paul, Manish C Choudhary, Amy L Heaps, et al.Pageof 7